{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:34:50Z","timestamp":1793230490304,"version":"4.5.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Dermatol Online J"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/idoj.idoj_29_19","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T03:24:32Z","timestamp":1561692272000},"page":"481","source":"Crossref","is-referenced-by-count":50,"title":["Topical ciclopirox olamine 1%: Revisiting a unique antifungal"],"prefix":"10.4103","volume":"10","author":[{"given":"Sidharth","family":"Sonthalia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahima","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VN","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-5178.261783-1","doi-asserted-by":"crossref","unstructured":"Markus A. Hydroxy-pyridones. Outstanding biological properties. In: Shuster S, editor. Hydroxy-Pyridones as Antifungal Agents with Special Emphasis on Onychomycosis. Berlin: Springer-Verlag; 1999. p. 1-10.","DOI":"10.1007\/978-3-642-58401-5_1"},{"key":"key-10.4103\/2229-5178.261783-2","first-page":"305","volume-title":"Ciclopirox: An overview","author":"Gupta","year":"2001","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/2229-5178.261783-3","first-page":"2133","volume-title":"Ciclopirox: Recent nonclinical and clinical data relevant to its use as a topical antimycotic agent","author":"Subissi","year":"2010","journal-title":"Drugs"},{"key":"key-10.4103\/2229-5178.261783-4","first-page":"296","volume-title":"In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity","author":"Gupta","year":"2003","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.261783-5","first-page":"330","volume-title":"Ciclopirox olamine 1% cream.A preliminary review of its antimicrobial activity and therapeutic use","author":"Jue","year":"1985","journal-title":"Drugs"},{"key":"key-10.4103\/2229-5178.261783-6","first-page":"95","volume-title":"Ciclopiroxolamine cream 1%: In vitro and in vivo penetration into the stratum comeum","author":"Ceschin-Roques","year":"1991","journal-title":"Skin Pharmacol"},{"key":"key-10.4103\/2229-5178.261783-7","first-page":"S57","volume-title":"Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis","author":"Bohn","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.261783-8","first-page":"537","volume-title":"In-vitro activity of 10 antifungal agents against 320 dermatophyte strains using microdilution method in Tehran","author":"Adimi","year":"2013","journal-title":"Iran J Pharm Res"},{"key":"key-10.4103\/2229-5178.261783-9","first-page":"471","volume-title":"Ciclopirox olamine: A hydroxypyridone antifungal agent","author":"Abrams","year":"1992","journal-title":"Clin Dermatol"},{"key":"key-10.4103\/2229-5178.261783-10","first-page":"788","volume-title":"Anti-inflammatory activity of antifungal preparations","author":"Rosen","year":"1997","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/2229-5178.261783-11","first-page":"594","volume-title":"Comparison of ciclopirox olamine 1% cream with ciclopirox 1%-hydrocortisone acetate 1% cream in the treatment of inflamed superrficial mycoses","author":"Lassus","year":"1988","journal-title":"Clin Ther"},{"key":"key-10.4103\/2229-5178.261783-12","first-page":"515","volume-title":"Topical ciclopirox - Recalling a forgotten ally in the fight against cutaneous mycoses","author":"Sonthalia","year":"2018","journal-title":"EC Microbiol"},{"key":"key-10.4103\/2229-5178.261783-13","first-page":"210","volume-title":"Multicentre double-blind clinical trials of ciclopirox olamine cream 1% in the treatment of tinea corporis and tinea cruris","author":"Bogaert","year":"1986","journal-title":"J Int Med Res"},{"key":"key-10.4103\/2229-5178.261783-14","first-page":"590","volume-title":"Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial","author":"Gupta","year":"2005","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/2229-5178.261783-15","first-page":"CD001434","volume-title":"Topical treatments for fungal infections of the skin and nails of the foot","author":"Crawford","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/2229-5178.261783-16","first-page":"409","volume-title":"Evaluation of ciclopirox olamine cream for the treatment of tinea pedis: Multicenter, double-blind comparative studies","author":"Kligman","year":"1985","journal-title":"Clin Ther"},{"key":"key-10.4103\/2229-5178.261783-17","first-page":"200","volume-title":"Topical application of a 0.1% ciclopiroxolamine solution for the treatment of pityriasis versicolor","author":"Corte","year":"1989","journal-title":"Mycoses"},{"key":"key-10.4103\/2229-5178.261783-18","first-page":"193","volume-title":"Topical treatment of facial seborrheic dermatitis: A systematic review","author":"Gupta","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"key-10.4103\/2229-5178.261783-19","doi-asserted-by":"crossref","unstructured":"Ratnavel RC, Squire RA, Boorman GC. Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis. J Dermatolog Treat 2007;18:88-96.","DOI":"10.1080\/16537150601092944"},{"key":"key-10.4103\/2229-5178.261783-20","first-page":"558","volume-title":"Clinical efficacy of a new ciclopiroxolamine\/zinc pyrithione shampoo in scalp seborrheic dermatitis treatment","author":"Lorette","year":"2006","journal-title":"Eur J Dermatol"},{"key":"key-10.4103\/2229-5178.261783-21","first-page":"51","volume-title":"A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff\/seborrhoeic dermatitis","author":"Squire","year":"2002","journal-title":"J Dermatol Treat"},{"key":"key-10.4103\/2229-5178.261783-22","first-page":"233","volume-title":"Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis","author":"Chosidow","year":"2003","journal-title":"Dermatology"},{"key":"key-10.4103\/2229-5178.261783-23","first-page":"153","volume-title":"Treatment of head and neck dermatitis with ciclopiroxolamine cream--results of a double-blind, placebo-controlled study","author":"Mayser","year":"2006","journal-title":"Skin Pharmacol Physiol"},{"key":"key-10.4103\/2229-5178.261783-24","first-page":"41","volume-title":"Evaluation of a new antifungal cream, ciclopirox olamine 1% in the treatment of cutaneous candidosis","author":"Bagatell","year":"1985","journal-title":"Clin Ther"},{"key":"key-10.4103\/2229-5178.261783-25","first-page":"29","volume-title":"A multi- center, open-label study to assess the safety and efficacy of ciclopirox topical suspension 0.77% in the treatment of diaper dermatitis due to Candida albicans","author":"Gallup","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/2229-5178.261783-26","first-page":"145","volume-title":"Allergic contact dermatitis from ciclopirox olamine","author":"Foti","year":"2001","journal-title":"Australas J Dermatol"},{"key":"key-10.4103\/2229-5178.261783-27","first-page":"164","volume-title":"Phase III study of the efficacy and safety of ciclopirox olamine cream in small children with dermatomycosis","author":"G\u00f3mez-Moyano","year":"2015","journal-title":"Rev Iberoam Micol"},{"key":"key-10.4103\/2229-5178.261783-28","first-page":"1440","volume-title":"Topical antiviral and antifungal medications in pregnancy: A review of safety profiles","author":"Patel","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:41:58Z","timestamp":1786732918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.IDOJ_29_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"alternative-id":["261783"],"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_29_19","relation":{},"ISSN":["2229-5178"],"issn-type":[{"value":"2229-5178","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}